Learning from the gut.

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

Who cites it

12 citing papers in PubMed.

1. Neuroprotective Mechanisms of Glucagon-Like Peptide-1-Based Therapies in Ischemic Stroke: An Update Based on Preclinical Research.Frontiers in neurology · 2022
   Review
2. Neuroprotective Actions of Glucagon-Like Peptide-1 (GLP-1) Analogues in Alzheimer's and Parkinson's Diseases.CNS drugs · 2019
   Review
3. The diabetes drug liraglutide reverses cognitive impairment in mice and attenuates insulin receptor and synaptic pathology in a non-human primate model of Alzheimer's disease.The Journal of pathology · 2018
   Article
4. Adaptive responses of neuronal mitochondria to bioenergetic challenges: Roles in neuroplasticity and disease resistance.Free radical biology & medicine · 2017
   Review
5. Glucagon-Like Peptide-1 and Its Class B G Protein-Coupled Receptors: A Long March to Therapeutic Successes.Pharmacological reviews · 2016
   Review
6. GLP-1 improves neuropathology after murine cold lesion brain trauma.Annals of clinical and translational neurology · 2014
   Article
7. Alzheimer's disease and insulin resistance: translating basic science into clinical applications.The Journal of clinical investigation · 2013
   Review
8. An anti-diabetes agent protects the mouse brain from defective insulin signaling caused by Alzheimer's disease- associated Aβ oligomers.The Journal of clinical investigation · 2012
   Article
9. Recruiting adaptive cellular stress responses for successful brain ageing.Nature reviews. Neuroscience · 2012
   Article
10. [Lifestyle and cognition: what do we know from the aging and neurodegenerative brain?].Der Nervenarzt · 2011
    Review
11. The impact of dietary energy intake on cognitive aging.Frontiers in aging neuroscience · 2010
    Article
12. Awareness of hormesis will enhance future research in basic and applied neuroscience.Critical reviews in toxicology · 2008
    Article

Corrections and comments

• Comment on
  Glucagon-like peptide-1 receptor is involved in learning and neuroprotection.2003

Authors and funding

3 authors.

Funding

Abstract

PubMed holds no abstract for this paper.

Indexed as